REFERENCES

1. Article 168(1) and 168(2) Treaty on Functioning of the European Union. Available from: http://data.europa.eu/eli/treaty/tfeu_2008/art_168/oj [Last accessed on 22 Dec 2021].

2. Article 168(7) Treaty on Functioning of the European Union. Available from: http://data.europa.eu/eli/treaty/tfeu_2008/art_168/oj [Last accessed on 22 Dec 2021].

3. GCEU 23 September 2020, ECLI:EU:T:2020:444, Case T-549/19 (Medac Gesellschaft für klinische Spezialpräparate mbH v EC). Available from: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A62019TJ0549 [Last accessed on 22 Dec 2021].

4. Regulation (EC) 726/2004. Available from: http://data.europa.eu/eli/reg/2004/726/2019-03-30 [Last accessed on 22 Dec 2021].

5. Regulation (EC) 2000/141. In particular, article 3(1)(b) of the Regulation. Regulation (EC) No 141/2000 of the European parliament and of the council of 16 December 1999 on orphan medicinal products. Available from: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=celex%3A32000R0141 [Last accessed on 27 Dec 2021].

6. Recitals 2, 3, 4 of the preambles to Regulation (EC) 1901/2006. Available from: https://eur-lex.europa.eu/legal-content/EN/TXT/HTML/?uri=CELEX:62009TJ0052&from=DA [Last accessed on 22 Dec 2021].

7. Kimland E, Odlind V. Off-label drug use in pediatric patients. Clin Pharmacol Ther 2012;91:796-801.

8. Drenska M, Grigorova V, Elitova S, Naseva E, Getov I. The off-label use of medicines in pediatric outpatients in Bulgaria based on an analysis of their prescription data. Drugs Ther Perspect 2019;35:391-5.

9. Article 10a Directive 2001/83/EC. DIRECTIVE 2001/83/EC OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 6 November 2001 on the Community code relating to medicinal products for human use (OJ L 311, 28.11.2001, p. 67). Available from: https://ec.europa.eu/health/sites/default/files/files/eudralex/vol-1/dir_2001_83_consol_2012/dir_2001_83_cons_2012_en.pdf [Last accessed on 22 Dec 2021].

10. Weda M, Hoebert J, Vervloet M, et al. Study on off-label use of medicinal products in the European Union. Available from: https://www.nivel.nl/nl/publicatie/study-label-use-medicinal-products-european-union [Last accessed on 22 Dec 2021].

11. Alenka BB, Vladimir B. The use of off-label drugs in medicine: ethical and legal issues. Biomedicine and Surgery 2017;1:84-7.

12. European Medicines Agency. Off-label use. Available from: https://www.ema.europa.eu/en/glossary/label-use. Accessed 20 May 2021 [Last accessed on 22 Dec 2021].

13. Declaration on Good Off-Label Use Practice. Available from: https://www.braincouncil.eu/wp-content/uploads/2018/07/GOLUP_Declaration.pdf [Last accessed on 22 Dec 2021].

14. Heads of Medicines Agencies. European Medicines Agencies Co-operation of Legal and Legislative Issues (EMACOLEX). Available from: https://www.hma.eu/482.html [Last accessed on 22 Dec 2021].

15. Elkins Z, Ginsburg T, Melton J. The endurance of National Constitutions. New York: Cambridge University Press; 2019.

16. Voermans W. Het verhaal van de grondwet: zoeken naar wij. Amsterdam: Prometheus; 2019.